Post Office Horizon Scandal Inquiry Faces FiveYear Delay Without Extra Funding Police Warn
Wells Fargo Upgrades Automatic Data Processing ADP to Equal Weight Sets 214 Target
Nifty Index Remains RangeBound Near 23800 Resistance as Volatility Declines
Mortgage Rates Show Mixed Movements as 30Year Fixed Declines and 15Year Rises
Meta Broadcom and Industry Leaders Invest 125 Million in UCLA Semiconductor Research Hub
AIA Engineering Targets Volume Growth with Mining Innovations Following Earnings Beat
CCCC Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction
OPTU Q1 2026 Earnings A Staggering EPS Miss Rattles Investors
QVCGA Q3 2025 Earnings Significant Loss Reported No Consensus Estimate Available
AMBP Q1 2026 Earnings Strong EPS Beat of 127 Surprise Amid Stock Decline
Lite Strategy Inc LITS Q4 2024 Earnings EPS Misses Estimates by Wide Margin Stock Declines
ASPI Q4 2025 Earnings Significant EPS Miss Overshadowed by Strong Stock Rally
Black Hawk Acquisition Corp Rights BKHAR Flat Near Support Key Levels Under Scrutiny
Dime Community Bancshares Preferred Stock Holds Steady at 1851 Amid Consolidation
STAK Inc STAK Declines 455 as Stock Hovers Near Key 10 Support Level
Vera Therapeutics VERA Edges Higher as Stock Tests Resistance Zone
Bicara Therapeutics BCAX Edges Higher as Stock Tests Key Resistance Zone
Darling Ingredients Q1 2026 Earnings Strong EPS Beat Surprises Analysts Stock Slides Slightly
European Household Energy Costs Show Divergent Trends Amid Geopolitical Tensions
Walmart CFO Notes Consumer Stress as High Fuel Prices Reduce Visits and Gallons Per FillUp
Erdoan Visits Astana as Turkey and Kazakhstan Target 13 Billion in Bilateral Trade
Greystone Housing Impact Investors Q1 2026 Earnings Significant EPS Miss Amid Challenging Housing Market
MPTI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
Ebola Risk Elevated to Very High in DR Congo Potential Implications for Regional Economies and Investors
NYAX Q1 2026 Earnings EPS Falls Short of Estimates Despite Strong Stock Reaction
Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867